Page 1

SANOFI 26th October 2021 The Secretary Bombay Stock Exchange Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 001 The Secretary The National Stock Exchange of India Limited Exchange Plaza , 5th Floor Plot No. C / 1 , G Block Bandra - Kurla Complex Bandra East , Mumbai 400 050 Unaudited Financial Results for the Quarter and Nine Months Ended 30th September 2021 Dear Sirs , We refer to our letter dated 13th October 2021 informing you of our Board Meeting that was scheduled today . The Meeting of Board of Directors commenced at 1.30 p.m. and concluded at 04.00 p.m. The Board approved unaudited financial results for the quarter and nine months ended 30th September 2021 . Pursuant to Regulation 33 of the SEBI ( Listing Obligations and Disclosure Requirements ) Regulations , 2015 , we enclose a copy of the unaudited financial results for the quarter and nine months ended 30th September 2021 approved at this Meeting along with a copy of the Limited Review Report duly signed by the Auditors of the Company . Please take the above information on record . Thanking you , For SANOFI INDIA LIMITED VAIBHAV Digitally signed by VINAYAK VAIBHAV VINAYAK KARANDIKAR KARANDIKAR Date : 2021.10.26 16:05:49 + 05'30 ' VAIBHAV KARANDIKAR WHOLE TIME DIRECTOR , CFO & COMPLIANCE OFFICER Sanofi India Limited , Sanofi House , CTS No. 117 - B , L & T Business Park , Saki Vihar Road , Powai , Mumbai 400 072 - India - Tel .: +91 ( 22 ) 2803 2000 - Fax : +91 ( 22 ) 2803 2939 Corporate Identity Number : L24239MH1956PLC009794 Website : www.sanofiindialtd.com Email : igrc.sil@sanofi.com